Evaluated by: David B. Kaminsky, M.D., FIAC, August 8, 2017
Original release date: August 8, 2017
Access to this course expires on: April 13, 2020, at 11:59 PM Pacific Time
USCAP announces with pride a unique interactive microscopy course dedicated to hematopoietic malignancies taught by proverbial giants in the field of neoplastic hematopathology. The morphologic detail and ancillary diagnostic studies required for accurate diagnosis and classification of this constellation of diseases require intense study and understanding of their criteria and differential considerations. Taking this course with these stellar hematopathologists will sharpen your skills with cutting-edge perspective.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 11 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Daniel A. Arber, M.D., Eric His, M.D., Attillio Orazi, M.D. FRCPath, Kaaren K. Reichard, M.D.
The following IM Coordinator reported no relevant financial relationships: Megan S. Lim, MD, PhD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
This item is expired.
Items Included in the Purchase of this Course
Lymphoproliferative Disorders of Blood and Marrow
Potpourri of Unusual Hematopoietic Tissue Infiltrates
Marrow Changes in Reactive Conditions